INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update
The Board of International Biotechnology Trust plc (the "Company") notes that an unquoted portfolio company that, for commercial reasons, cannot currently be named has been written down by £1.5m.
The Directors have changed the valuation of the Company's interest in this unquoted company from £2.7m to £1.2m on a cost of £3.7m to reflect the fact that business development discussions over the past six months have not produced a deal with an external party reflective of the valuation placed on this company. This change in valuation will be included in the Company's Net Asset Value ("NAV") at close of business yesterday and will be released to the market today. The reduction in NAV per share in comparison to that released yesterday is 2.69 pence per share.
Enquiries:
Kate Bingham/David Pinniger
Telephone: 020 7412 7070
SV Life Sciences Managers LLP
Investment Manager
Rhona Gregg
Telephone: 0141 225 3009
BNP Paribas Secretarial Services Limited
Company Secretary
7 JULY 2011